The UTEL OTDR can be connected to the input of a UTEL OS-36 to provide test access for multiple fibres. The Optical Test Access Switches can be organised in a cascaded arrangement, which means a single UTEl OTDR can test an entire Optical Distribution Frame(ODF). The OTDR can be controlled remotely using TL1, XML or UTELs bespoke test management software.
Aetna considers pembrolizumab (Keytruda) medically necessary for the following indications: 1  Colorectal cancer - single agent therapy for. Primary treatment for unresectable metachronous metastases and previous adjuvant FOLFOX or CapeOX within the past 12 months; or.
He then gave the alarming example of a drug that would cost more than $1 million. The latest immunotherapy, pembrolizumab (Keytruda, Merck Sharp & Dohme Corp), was approved at the end of 2014 for use at a dose of 2 mg/kg for the treatment of melanoma. For this, it costs around $14,500 per month.HICAGO â One of the new immunotherapies would cost more than $1 million per patient per year at the higher dose currently being studied in many different cancer types, an expert has warned. This is unsustainable....